Skip to main content

Table 1 Comparison of clinical and biochemical parameters between the control group and the group of obese patients with hypertension, the group of patients with mildly elevated lipids and the group of patients with normal-weight hypertension

From: The associations between some biological markers, obesity, and cardiovascular risk in Slovenian children and adolescents

Parameters/Mean ± SD (p-value)

Control group (N = 35)

Obese patients with hypertension (N = 92)

Patients with mildly elevated lipids (N = 99)

Normal-weight patients with hypertension (N = 104)

Age (years)

11.3 ± 4.6

12.4 ± 4.3 (N)

11.3 ± 3.8 (N)

13.3 ± 4.6 (N)

Body weight (kg)

45.9 ± 20.2

75.5 ± 26.3 (< 0.001)

73.4 ± 31.8 (< 0.001)

58.4 ± 22.4 (N)

Body height (cm)

149.3 ± 24.4

159.9 ± 20.7 (N)

155.4 ± 22.0 (N)

161.3 ± 25.7 (N)

BMI (kg/m2)

19.5 ± 3.9

28.0 ± 5.1 (< 0.001)

28.5 ± 7.9 (< 0.001)

20.8 ± 3.8 (0.004)

Waist circumference (cm)

69.5 ± 11.9

92.6 ± 15.6 (< 0.001)

93.4 ± 21.6 (< 0.001)

75.2 ± 12.8 (0.03)

Hip circumference (cm)

82.3 ± 12.4

101 ± 15.6 (< 0.001)

99.7 ± 20.0 (< 0.001)

88.3 ± 15.0 (N)

Systolic blood pressure (mmHg)

115.5 ± 9.5

128.3 ± 9.5 (< 0.001)

123.0 ± 15.5 (0.009)

126.8 ± 11.5 (< 0.001)

Diastolic blood pressure (mmHg)

68.5 ± 6.8

71.4 ± 8.1 (N)

75.8 ± 11.8 (< 0.001)

70.6 ± 7.9 (N)

Glucose (mmol/l)

4.9 ± 0.9

4.9 ± 0.7 (N)

4.8 ± 0.5 (N)

4.7 ± 0.4 (N)

Total cholesterol (mmol/l)

4.1 ± 0.7

4.4 ± 0.5 (N)

4.6 ± 1.0 (0.045)

4.2 ± 0.93 (N)

Triglycerides (mmol/l)

0.96 ± 0.5

1.3 ± 0.96 (0.059)

1.18 ± 0.6 (N)

0.91 ± 0.4 (N)

HDL cholesterol (mmol/l)

1.6 ± 0.5

1.2 ± 0.3 (< 0.001)

1.3 ± 0.4 (0.002)

1.5 ± 0.4 (N)

LDL cholesterol (mmol/l)

2.3 ± 0.6

2.8 ± 0.6 (0.030)

2.9 ± 0.9 (0.005)

2.7 ± 1.2 (N)

Apolipoprotein A1 (g/l)

1.5 ± 0.3

1.4 ± 0.2 (N)

1.4 ± 0.2 (N)

1.5 ± 0.24 (N)

Homocysteine (μmol/l)

8.6 ± 2.4

10.4 ± 5.1 (N)

7.9 ± 2.2 (N)

10.1 ± 4.0 (N)

  1. BMI body mass index, N nonsignificant